We provide cutting edge research about newly approved and emerging treatments for leukemia, lymphoma, and myeloma to hematologists and oncologists who diagnose and treat patients with hematologic malignancies.

Optimizing Clinical Outcomes in Blood Cancers Through Groundbreaking Translational Research

This activity will provide learners with the latest developments in translational medicine for leukemia, lymphoma, and myeloma and how these developments can be incorporated into regimens to improve the outcome of patients with these diseases.